These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 17979738)

  • 1. Trends in snakebite envenomation therapy: scientific, technological and public health considerations.
    Gutiérrez JM; Lomonte B; León G; Rucavado A; Chaves F; Angulo Y
    Curr Pharm Des; 2007; 13(28):2935-50. PubMed ID: 17979738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical Evaluation of the Efficacy of Antivenoms for Snakebite Envenoming: State-of-the-Art and Challenges Ahead.
    Gutiérrez JM; Solano G; Pla D; Herrera M; Segura Á; Vargas M; Villalta M; Sánchez A; Sanz L; Lomonte B; León G; Calvete JJ
    Toxins (Basel); 2017 May; 9(5):. PubMed ID: 28505100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From Fangs to Pharmacology: The Future of Snakebite Envenoming Therapy.
    Laustsen AH; Engmark M; Milbo C; Johannesen J; Lomonte B; Gutiérrez JM; Lohse B
    Curr Pharm Des; 2016; 22(34):5270-5293. PubMed ID: 27339430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Search for Natural and Synthetic Inhibitors That Would Complement Antivenoms as Therapeutics for Snakebite Envenoming.
    Gutiérrez JM; Albulescu LO; Clare RH; Casewell NR; Abd El-Aziz TM; Escalante T; Rucavado A
    Toxins (Basel); 2021 Jun; 13(7):. PubMed ID: 34209691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antivenom for snakebite envenoming in Sri Lanka: the need for geographically specific antivenom and improved efficacy.
    Keyler DE; Gawarammana I; Gutiérrez JM; Sellahewa KH; McWhorter K; Malleappah R
    Toxicon; 2013 Jul; 69():90-7. PubMed ID: 23454626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antivenoms for snakebite envenomings.
    Gutiérrez JM; León G; Lomonte B; Angulo Y
    Inflamm Allergy Drug Targets; 2011 Oct; 10(5):369-80. PubMed ID: 21745181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of antivenoms in the treatment of snake envenomation].
    Chippaux JP
    Bull Acad Natl Med; 2013; 197(4-5):993-1006; discussion 1006-8. PubMed ID: 25518165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological re-assessment of traditional medicinal plants-derived inhibitors as antidotes against snakebite envenoming: A critical review.
    Puzari U; Fernandes PA; Mukherjee AK
    J Ethnopharmacol; 2022 Jun; 292():115208. PubMed ID: 35314419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ending the drought: new strategies for improving the flow of affordable, effective antivenoms in Asia and Africa.
    Williams DJ; Gutiérrez JM; Calvete JJ; Wüster W; Ratanabanangkoon K; Paiva O; Brown NI; Casewell NR; Harrison RA; Rowley PD; O'Shea M; Jensen SD; Winkel KD; Warrell DA
    J Proteomics; 2011 Aug; 74(9):1735-67. PubMed ID: 21640209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing the impact of snakebite envenoming in Latin America and the Caribbean: achievements and challenges ahead.
    Gutiérrez JM
    Trans R Soc Trop Med Hyg; 2014 Sep; 108(9):530-7. PubMed ID: 25096295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Snakebite envenoming from a global perspective: Towards an integrated approach.
    Gutiérrez JM; Williams D; Fan HW; Warrell DA
    Toxicon; 2010 Dec; 56(7):1223-35. PubMed ID: 19951718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overlooked issues of snakebite management: time for strategic approach.
    Girish KS; Kemparaju K
    Curr Top Med Chem; 2011; 11(20):2494-508. PubMed ID: 21699494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The development and use of immunotherapy in Africa.
    Chippaux JP
    Toxicon; 1998 Nov; 36(11):1503-6. PubMed ID: 9792164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anti snake venom crisis in Africa: a suggested manufacturers product guide.
    Simpson ID; Blaylock RS
    Wilderness Environ Med; 2009; 20(3):275-82. PubMed ID: 19737031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Needs and availability of snake antivenoms: relevance and application of international guidelines.
    Scheske L; Ruitenberg J; Bissumbhar B
    Int J Health Policy Manag; 2015 Apr; 4(7):447-57. PubMed ID: 26188809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxin-centric development approach for next-generation antivenoms.
    Laustsen AH
    Toxicon; 2018 Aug; 150():195-197. PubMed ID: 29857088
    [No Abstract]   [Full Text] [Related]  

  • 17. Stability, distribution and use of antivenoms for snakebite envenomation in Latin America: report of a workshop.
    Gutiérrez JM; Fan HW; Silvera CL; Angulo Y
    Toxicon; 2009 May; 53(6):625-30. PubMed ID: 19673076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune response towards snake venoms.
    León G; Sánchez L; Hernández A; Villalta M; Herrera M; Segura A; Estrada R; Gutiérrez JM
    Inflamm Allergy Drug Targets; 2011 Oct; 10(5):381-98. PubMed ID: 21824081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic-pharmacodynamic relationships of immunoglobulin therapy for envenomation.
    Gutiérrez JM; León G; Lomonte B
    Clin Pharmacokinet; 2003; 42(8):721-41. PubMed ID: 12846594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Understanding snake venoms: 50 years of research in Latin America].
    Gutiérrez JM
    Rev Biol Trop; 2002 Jun; 50(2):377-94. PubMed ID: 12298273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.